Skip to main content
. Author manuscript; available in PMC: 2013 May 7.
Published in final edited form as: Mol Pharm. 2012 Apr 21;9(5):1441–1448. doi: 10.1021/mp300019c

Figure 2.

Figure 2

Serial PET imaging of 4T1 tumor-bearing mice. (A) Coronal PET images at 4, 20, and 36 h post-injection of 66Ga-NOTA-TRC105, 2 mg of TRC105 before 66Ga-NOTA-TRC105 (i.e. blocking), or 66Ga-NOTA-cetuximab. (B) Representative PET/CT images of 66Ga-NOTATRC105 in 4T1 tumor-bearing mice at 20 h post-injection. Tumors are indicated by arrowheads.